Livingstone Health Holdings Limited

Livingstone Health Holdings Limited

SSGX:PRH
0.02
SGD
+0.00
(-4.17%)
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
11.41
3.28
0.18
1.57
2.67
0.74
- -
0.21
0.11
0.08
0.06
0.05
0.05
- -
Basic EPS, GAAP
-0.9
0.09
-0.42
-0.28
0.05
-0.01
- -
0.02
0.01
- -
-0.01
- -
- -
- -
Free Cash Flow per Basic Share
0.14
-0.4
-0.12
-0.1
0.03
-0.01
- -
-0.01
0.01
- -
- -
0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.3
0.25
-0.14
-0.48
-0.43
- -
- -
-0.02
0.02
0.01
0.01
0.01
0.01
-0.01
Tangible Book Value per Share
-0.37
0.19
-0.14
-0.48
-0.43
- -
- -
-0.02
- -
- -
- -
- -
- -
-0.01
Basic Weighted Avg Shares
7
21
30
30
30
74
83
83
319
436
442
580
624
83
Sales/Revenue/Turnover
81
70
5
47
80
55
- -
18
34
33
25
28
29
- -
Operating Margin (%)
-3.9
4.64
-52.02
-2.09
3.23
-0.81
-222.14
21.14
14.44
7.32
-4.96
1.43
-0.52
- -
Depreciation Expense
1
- -
- -
- -
- -
- -
- -
- -
2
2
2
3
2
- -
Net Income, GAAP
-6
2
-12
-8
2
-1
- -
1
3
1
-3
1
- -
- -
Effective Tax Rate (%)
- -
4.39
- -
- -
- -
- -
- -
24.69
16.57
28.45
- -
- -
- -
- -
Profit Margin (%)
-7.84
2.86
-236.22
-17.55
1.89
-1.16
9.92
8.24
8.86
2.2
-11.32
2.01
0.76
- -
Working Capital
- -
1
-10
-14
-13
- -
- -
- -
3
1
1
- -
- -
- -
LT Debt
11
4
3
- -
- -
- -
1
1
4
4
5
2
2
1
Total Equity
- -
9
-4
-14
-13
- -
- -
-1
6
6
5
5
5
-1
Return on Invested Capital (%)
- -
11.81
- -
- -
-56.06
- -
- -
- -
50.71
11.11
- -
- -
- -
- -
Return on Capital (%)
- -
13.84
- -
- -
-34.91
- -
- -
605.43
43
2.53
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
14.18
-64.25
10.97
3.35
- -

Capital Structure

SGD

•

in mil. unless spec.
Sep'19
Dec'19
Jun'20
ST Debt
- -
- -
- -
LT Borrowings
- -
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
83
83
83
Market Capitalization
- -
- -
- -

Working Capital

SGD

•

in mil. unless spec.
Sep'19
Dec'19
Jun'20
Total Current Assets
4
1
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
4
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.85%
-100.45%
-7.88%
Free Cash Flow
6.88%
27.63%
-30.93%
Net Income, GAAP
1,008.14%
-129.12%
-59.96%
Sales/Revenue/Turnover
1,423.88%
16.23%
5.93%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
25
2025
- -
- -
28
2026
- -
- -
29

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.01
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Ching Yit Tay
Full Time Employees
91
Sector
Non-energy minerals
Industry
Other metals/Minerals
Address
Singapore Singapore
IPO Date
Nov 24, 2004
Business
Livingstone Health Holdings Limited is a Singapore-based multidisciplinary healthcare services provider that operates an integrated network of medical clinics, specialized treatment centers, and allied health facilities. Founded in 2014 and headquartered in Singapore, the company provides comprehensive healthcare solutions organized across five principal operating segments: Orthopaedics; Aesthetics and Wellness; Anaesthesiology and Pain Management; Internal Medicine; and Allied Healthcare and Primary Services. The Orthopaedics division provides adult and paediatric musculoskeletal care; spine and spinal deformity surgery; joint reconstruction and replacement; sports injury management; arthroscopic interventions; and trauma surgery. The Aesthetics and Wellness segment delivers non-invasive and minimally invasive aesthetic treatments; cosmetic dermatology; laser skin rejuvenation; body contouring; anti-aging therapies; medical facials; and specialized skincare formulations under branded clinical concepts such as Cove Aesthetic Clinic. The Anaesthesiology and Pain Management segment offers perioperative anaesthesia; chronic and acute pain interventions; nerve blocks; spinal injections; musculoskeletal pain relief; and critical care support. The Internal Medicine division delivers diagnostic and disease management services covering cardiology, gastroenterology, respiratory medicine, endocrinology, chronic illness management, and customized executive health screenings. The Allied Healthcare and Primary Services segment provides musculoskeletal physiotherapy; sports rehabilitation; chiropractic care; podiatry; family medicine; occupational health; corporate wellness management; and telemedicine consultations. Geographically, the group operates predominantly in Singapore while extending its footprint across Southeast Asia through clinical management, medical consultancy, and patient referral networks in Malaysia and Cambodia. In recent developments, Livingstone Health Holdings Limited has actively expanded its operational footprint through strategic joint ventures, clinic network optimization, and targeted acquisitions within the primary care, rehabilitation, and aesthetic medical segments. The company has deepened its regional footprint via cross-border patient concierge and healthcare management partnerships, launched expanded multidisciplinary physiotherapy and rehabilitation centers, and diversified its revenue base through the commercialization of proprietary health and wellness retail products alongside integrated digital healthcare platforms.